Reduce animal testing by implementing the 3D CoSeedis™ Cytotoxicity in chip Assay

As an outstanding service provider with its own proprietary 3D technology in the field of preclinical disease models, abc biopply has developed unique and groundbreaking assays to streamline and fasten drug discovery, characterization and optimization.
The 3D CoSeedis™ Cytotoxicity in chip Assay is part of abc biopply's preclinical 360° study cycle. It has demonstrated increasing clinical predictive power, improved cost effectiveness and reduced the need for animal testing in numerous projects.
Today, I would like to present the 3D CoSeedis™ Cytotoxicity in chip Assay. It belongs to abc biopply’s family of in chip-assays and is optimized for 3D cell culture. It benefits from the advantages of the 3D CoSeedis™ chip by enabling the cultivation of hundreds of uniform and homogenous 3D cultures under physiological conditions that can be analyzed simultaneously for higher statistical relevance and sensitivity.
Major benefits of the 3D CoSeedis™ Cytotoxicity in chip Assay include:
  • It integrates the signal of 680 3D cultures per data point
  • It therefore eliminates any outliers within a dataset
  • It consequently generates highly reliable results
  • It leads to a much higher accuracy in predicting drug function and efficacy
Interested to learn more about the 3D CoSeedis™ Cytotoxicity in chip Assay or any of the other in chip-assay family members? I am looking forward to answering all your questions.

   Best regards

   Marco Leu, PhD
   Sales & Operation
   abc biopply ag

   Direct Email / Phone +41 (0)79 834 95 56


Back to overview

Contact us